International Women’s Day: breaking barriers, building gender and health equity
On International Women’s Day, we join forces to collectively strive for gender and health equity, empowering women in and beyond our company.
Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies
Landmark EMPA-KIDNEY trial showed significant benefit of Jardiance® in reducing kidney disease progression or cardiovascular death by 28% vs. placebo in people with chronic kidney disease
Explore our News & Stories
Stay up to date with helpful information, announcements, and trending topics.
Corporate Profile
Breakthrough in Artificial Intelligence
Is ChatGPT the AI revolution we were waiting for or only media hype? Experts from Boehringer Ingelheim take a close look.
Corporate Profile
Milan site opens its doors to dogs at work
Milan offices welcome dogs at work and enjoy all the benefits they bring to their daily work life.
Corporate Profile
Earthquakes Türkiye & Syria
Support for those impacted by Türkiye & Syria earthquakes: Additional Türkiye and Syria relief actions raise company contribution to EUR 1 million
Vision & Values
Research that touches lives
Our Head of Global Innovation Animal Health, Eric Haaksma, speaks about the joy of seeking answers to complex questions.
Corporate Profile
Heart disease and treatments can be similar in humans and animals. How?
Humans and animals are more alike than different. Having a heart disease can affect us similarly, and the way to prevent it can work for all as well. Watch and learn how
Vision & Values
Data science, agile working, UX design: our evolving IT careers
Our IT is constantly evolving, further developing their skills, tools and processes, based on what Boehringer Ingelheim needs today and tomorrow.
